trametinibthrombinAngiotensin llT2DMtype 2 diabetes mellitus (T2DM)Saphenous vein graft failure
…non-diabetic controls. Inhibition of MEK1/2-ERK1/2 pathway with trametinib resulted in significant reduction in the generation of mROS in …
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…non-diabetic controls. Inhibition of MEK1/2-ERK1/2 pathway with trametinib resulted in significant reduction in the generation of mROS in …